Circulating Sclerostin Levels Are Decreased in Patients with Endogenous Hypercortisolism and Increase after Treatment

A.H. van Lierop, A.W. van der Eerden, N.A.T. Hamdy, A.R. Hermus, M. den Heijer, S.E. Papapoulos

Research output: Contribution to journalArticleAcademicpeer-review

135 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)E1953-E1957
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number10
DOIs
Publication statusPublished - 2012

Cite this